Edition:
United Kingdom

Insider Trading: Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

0.57USD
23 Aug 2019
Change (% chg)

$-0.04 (-5.74%)
Prev Close
$0.61
Open
$0.61
Day's High
$0.62
Day's Low
$0.57
Volume
11,415
Avg. Vol
33,337
52-wk High
$1.32
52-wk Low
$0.55

All Insider Trades
Trading Date Name Title Type Shares Traded Price
12 Jun 2019

Wang (Theodore T)

Director and Beneficial Owner Buy 50,000 $0.64
22 May 2019

Wang (Theodore T)

Director and Beneficial Owner Buy 27,500 $0.60
22 May 2019

Edmonds (Amy)

Officer Sell 35,827 $0.61
21 May 2019

Wang (Theodore T)

Director and Beneficial Owner Buy 43,280 $0.61
21 May 2019

Peacock (Jonathan M)

Director Buy 20,000 $0.61
21 May 2019

Tenenbaum (Fabian)

Chief Executive Officer Buy 5,000 $0.60
25 Jan 2019

Peacock (Jonathan M)

Director Buy 714,286 $0.70
25 Jan 2019

Amin (Naseem M.D.)

Director Buy 571,429 $0.70
25 Jan 2019

Wang (Theodore T)

Director and Beneficial Owner Buy 450,000 $0.70
23 Jan 2019

Peacock (Jonathan M)

Director Buy 227,273 $0.00
23 Jan 2019

VENROCK ASSOCIATES IV L P

Beneficial Owner of More than 10% Class Buy 142,857 $0.70
25 Sep 2018

Dekker (Martin)

Officer Buy 82,243 $0.00
25 Sep 2018

Korner (Assaf)

Chief Financial Officer Buy 99,065 $0.00
25 Sep 2018

Tenenbaum (Fabian)

Chief Executive Officer Buy 224,299 $0.00
25 Sep 2018

Shah (Parag Suresh)

Officer Buy 78,505 $0.00
25 Sep 2018

Edmonds (Amy)

Officer Buy 82,243 $0.00
25 Sep 2018

Fernandes (Peter)

Officer Buy 119,626 $0.00
17 Sep 2018

VENROCK ASSOCIATES IV L P

Beneficial Owner of More than 10% Class Buy 60,000 $1.18
14 Sep 2018

VENROCK ASSOCIATES IV L P

Beneficial Owner of More than 10% Class Buy 75,000 $1.23
13 Sep 2018

VENROCK ASSOCIATES IV L P

Beneficial Owner of More than 10% Class Buy 75,000 $1.19
12 Sep 2018

VENROCK ASSOCIATES IV L P

Beneficial Owner of More than 10% Class Buy 75,000 $1.15
11 Sep 2018

VENROCK ASSOCIATES IV L P

Beneficial Owner of More than 10% Class Buy 200,000 $1.14
10 Sep 2018

VENROCK ASSOCIATES IV L P

Beneficial Owner of More than 10% Class Buy 200,000 $1.22
7 Sep 2018

VENROCK ASSOCIATES IV L P

Beneficial Owner of More than 10% Class Buy 60,000 $0.90
6 Sep 2018

VENROCK ASSOCIATES IV L P

Beneficial Owner of More than 10% Class Buy 50,000 $0.84

Institutional Holders

% Shares Owned: 54.72%
# of Holders: 31
Total Shares Held: 37,706,901
3 Mo. Net Change: 20,800
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2

Officers & Directors

Name Age Since Current Position

Jonathan Peacock

59 2016 Chairman of the Board, President

Fabian Tenenbaum

42 2016 Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Director

Assaf Korner

40 2018 Chief Financial Officer

Martin Meglasson

65 2014 Chief Scientific Officer, Vice President

Reinilde Heyrman

54 2014 Vice President, Chief Clinical Development Officer and Secretary

Martin Dekker

42 2015 Vice President - Device Engineering

Manesh Naidu

45 2014 Vice President, Chief Business Officer

Daniel Tasse

59 2014 Director

Theodore Wang

52 2017 Director

Naseem Amin

2015 Independent Director

Matthew Bennett

46 2018 Independent Director

Scott Bruder

53 2015 Independent Director

Mary Cloyd

2016 Independent Director

Jens Luehring

41 Independent Director

Andre Moura

33 2014 Independent Director

Robert Nelsen

55 2014 Independent Director